AIMS: Prolonged QRS duration (QRSd) on the electrocardiogram (ECG) has been associated with cardiac structural and functional abnormalities by echocardiography and an increased risk of heart failure (HF). Data are sparse on these relationships in middle-aged and elderly individuals free of baseline cardiovascular disease with respect to cardiac magnetic resonance imaging (MRI). We sought to determine whether QRSd is associated with incident HF and measures of cardiac structure and function by cardiac MRI. METHODS AND RESULTS: We analysed baseline ECGs in the Multi-Ethnic Study of Atherosclerosis (MESA) to determine whether QRSd >100 ms was associated with incident HF. We adjusted for demographic and clinical risk factors, as well as MRI measures of left ventricular (LV) structure and function. Among 4591 eligible participants (51% women; 39% white; mean age 61 years), 75 developed incident HF over a mean follow-up of 7.1 years. QRSd >100 ms was significantly associated with MRI measures of cardiac structure and function, as well as incident HF, even after adjustment for demographic covariates [hazard ratio (HR) 2.10, 95% confidence interval (CI) 1.29-3.42; P = 0.003] and clinical risk factors (HR 1.86, 95% CI 1.14-3.03; P = 0.01). With further adjustment for individual LV structural measures, findings were attenuated to non-significance. Separate adjustment for LV functional measures yielded only mild attenuation. CONCLUSION: In middle-aged and older adults without cardiovascular disease, a QRSd >100 ms was significantly associated with incident HF. After adjustment for LV structural measures, the association was attenuated to non-significance, suggesting that prolonged QRSd is potentially a useful marker of LV structure that may predispose to HF risk.
AIMS: Prolonged QRS duration (QRSd) on the electrocardiogram (ECG) has been associated with cardiac structural and functional abnormalities by echocardiography and an increased risk of heart failure (HF). Data are sparse on these relationships in middle-aged and elderly individuals free of baseline cardiovascular disease with respect to cardiac magnetic resonance imaging (MRI). We sought to determine whether QRSd is associated with incident HF and measures of cardiac structure and function by cardiac MRI. METHODS AND RESULTS: We analysed baseline ECGs in the Multi-Ethnic Study of Atherosclerosis (MESA) to determine whether QRSd >100 ms was associated with incident HF. We adjusted for demographic and clinical risk factors, as well as MRI measures of left ventricular (LV) structure and function. Among 4591 eligible participants (51% women; 39% white; mean age 61 years), 75 developed incident HF over a mean follow-up of 7.1 years. QRSd >100 ms was significantly associated with MRI measures of cardiac structure and function, as well as incident HF, even after adjustment for demographic covariates [hazard ratio (HR) 2.10, 95% confidence interval (CI) 1.29-3.42; P = 0.003] and clinical risk factors (HR 1.86, 95% CI 1.14-3.03; P = 0.01). With further adjustment for individual LV structural measures, findings were attenuated to non-significance. Separate adjustment for LV functional measures yielded only mild attenuation. CONCLUSION: In middle-aged and older adults without cardiovascular disease, a QRSd >100 ms was significantly associated with incident HF. After adjustment for LV structural measures, the association was attenuated to non-significance, suggesting that prolonged QRSd is potentially a useful marker of LV structure that may predispose to HF risk.
Authors: Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart Journal: J Am Soc Echocardiogr Date: 2005-12 Impact factor: 5.251
Authors: Margaret M Redfield; Steven J Jacobsen; Barry A Borlaug; Richard J Rodeheffer; David A Kass Journal: Circulation Date: 2005-10-03 Impact factor: 29.690
Authors: Ravi Dhingra; Byung Ho Nam; Emelia J Benjamin; Thomas J Wang; Martin G Larson; Ralph B D'Agostino; Daniel Levy; Ramachandran S Vasan Journal: J Am Coll Cardiol Date: 2005-03-01 Impact factor: 24.094
Authors: Shunsuke Natori; Shenghan Lai; J Paul Finn; Antoinette S Gomes; W Gregory Hundley; Michael Jerosch-Herold; Gregory Pearson; Shantanu Sinha; Andrew Arai; Joao A C Lima; David A Bluemke Journal: AJR Am J Roentgenol Date: 2006-06 Impact factor: 3.959
Authors: Ravi Dhingra; Michael J Pencina; Thomas J Wang; Byung-Ho Nam; Emelia J Benjamin; Daniel Levy; Martin G Larson; William B Kannel; Ralph B D'Agostino; Ramachandran S Vasan Journal: Hypertension Date: 2006-04-03 Impact factor: 10.190
Authors: Heather J Shenkman; Vijayamalini Pampati; Akshay K Khandelwal; John McKinnon; David Nori; Scott Kaatz; Keisha R Sandberg; Peter A McCullough Journal: Chest Date: 2002-08 Impact factor: 9.410
Authors: Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy Journal: Am J Epidemiol Date: 2002-11-01 Impact factor: 4.897
Authors: Nikhil Patel; Wesley T O'Neal; S Patrick Whalen; Elsayed Z Soliman Journal: Ann Noninvasive Electrocardiol Date: 2017-06-29 Impact factor: 1.468
Authors: Zhu-Ming Zhang; Pentti M Rautaharju; Ronald J Prineas; Laura Loehr; Wayne Rosamond; Elsayed Z Soliman Journal: J Card Fail Date: 2015-01-09 Impact factor: 5.712
Authors: Stephen T Broughton; Wesley T O'Neal; Mouaz Al-Mallah; David A Bluemke; Susan R Heckbert; Joao A C Lima; Elsayed Z Soliman Journal: Int J Cardiol Date: 2017-12-15 Impact factor: 4.164
Authors: Wesley T O'Neal; Waqas T Qureshi; Saman Nazarian; Nadine Kawel-Boehm; David A Bluemke; Joao A C Lima; Elsayed Z Soliman Journal: Clin Cardiol Date: 2016-08-23 Impact factor: 2.882
Authors: Kyndaron Reinier; Aapo L Aro; Audrey Uy-Evanado; Carmen Rusinaru; Harpriya S Chugh; Takahiro Shiota; Jonathan Jui; Sumeet S Chugh Journal: Ann Noninvasive Electrocardiol Date: 2018-08-20 Impact factor: 1.468
Authors: Baris Gencer; Javed Butler; Douglas C Bauer; Reto Auer; Andreas Kalogeropoulos; Pedro Marques-Vidal; William B Applegate; Suzanne Satterfield; Tamara Harris; Anne Newman; Eric Vittinghoff; Nicolas Rodondi Journal: Am Heart J Date: 2014-04-05 Impact factor: 4.749
Authors: Stefanie Aeschbacher; Wesley T O'Neal; Philipp Krisai; Laura Loehr; Lin Y Chen; Alvaro Alonso; Elsayed Z Soliman; David Conen Journal: Int J Cardiol Date: 2018-09-01 Impact factor: 4.164
Authors: Amrita Pal; Fernando Martinez; Andrea P Aguila; Margaret A Akey; Roopsha Chatterjee; Merry Grace E Conserman; Ravi S Aysola; Luke A Henderson; Paul M Macey Journal: J Clin Sleep Med Date: 2021-03-01 Impact factor: 4.062